Anton Kraxner
Impact in
- Infectious Diseases top 10%
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
-
- Mosquito-borne diseases and control
- Malaria Research and Control
Papers in
- Oncology 7
- Peptidase Inhibition and Analysis 6
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Lucie Peduto (1 shared paper)Thérèse Couderc (1 shared paper)Nicolas Gangneux (1 shared paper)Marc Lecuit (1 shared paper)Marion Sourisseau (1 shared paper)Matthew L. Albert (1 shared paper)Stephen Higgs (1 shared paper)Olivier Schwartz (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)Journal of Clinical Oncology (2 papers)The Journal of Experimental Medicine (1 paper)Clinical Cancer Research (1 paper)Annals of Oncology (1 paper)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Anton Kraxner
9 papers receiving 303 citations
Peers
Comparison fields: 5 of 34
- Infectious Diseases 195
- Public Health, Environmental and Occupational Health 210
- Virology 25
- Immunology 91
- Oncology 55
Countries citing papers authored by Anton Kraxner
This map shows the geographic impact of Anton Kraxner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Kraxner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Kraxner more than expected).
Fields of papers citing papers by Anton Kraxner
This network shows the impact of papers produced by Anton Kraxner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Kraxner. The network helps show where Anton Kraxner may publish in the future.
Co-authors
The 25 scholars most cited alongside Anton Kraxner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 251 | |
| 2 | 2021 | 19 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 8 | |
| 5 | 2021 | 7 | |
| 6 | 2023 | 4 | |
| 7 | 2021 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2021 | 1 |
About Anton Kraxner
Anton Kraxner is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology and Cancer Research, having authored 9 papers that have together received 309 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Ubiquitin and proteasome pathways (2 papers), Cancer Genomics and Diagnostics (1 paper), interferon and immune responses (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Infectious Diseases (195 citations), Public Health, Environmental and Occupational Health (210 citations), Virology (25 citations), Immunology (91 citations) and Oncology (55 citations). Anton Kraxner has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Lucie Peduto, Thérèse Couderc, Nicolas Gangneux, Marc Lecuit, Marion Sourisseau, Matthew L. Albert, Stephen Higgs, Olivier Schwartz, Alain Michault and Florence Guivel‐Benhassine. Their work appears in journals such as Frontiers in Immunology, Journal of Clinical Oncology, The Journal of Experimental Medicine, Clinical Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.